This is not the most recent version of the article. View current version (21 JAN 2009)

Intervention Protocol

Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours

  1. KS Gurusamy,
  2. D Sharma,
  3. BR Davidson

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 23 APR 2008

DOI: 10.1002/14651858.CD007118


How to Cite

Gurusamy KS, Sharma D, Davidson BR. Palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD007118. DOI: 10.1002/14651858.CD007118.

Author Information

*Dr Kurinchi Selvan Gurusamy, Research Fellow, University Department of Surgery, Royal Free and University College School of Medicine,, 9th Floor, Royal Free Hospital,, Pond Street, London, NW3 2QG, UK. kurinchi2k@hotmail.com.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 23 APR 2008

SEARCH

This is not the most recent version of the article. View current version (21 JAN 2009)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the benefits and harms of palliative cytoreductive surgery versus other palliative treatments in patients with unresectable liver metastases from gastro-entero-pancreatic neuroendocrine tumours.